Deborah Grady

Author PubWeight™ 130.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 2006 6.14
2 Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med 2009 5.58
3 Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2003 5.38
4 The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence. Ann Intern Med 2006 3.93
5 Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004 3.39
6 Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002 3.13
7 Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study. Arch Intern Med 2011 3.00
8 Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. JAMA 2002 2.73
9 Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med 2002 2.69
10 The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol 2006 2.64
11 Diagnostic tests: another frontier for less is more: or why talking to your patient is a safe and effective method of reassurance. Arch Intern Med 2010 2.49
12 Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors. Circulation 2009 2.41
13 Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol 2002 2.41
14 Evaluation of abnormal mammography results and palpable breast abnormalities. Ann Intern Med 2003 2.20
15 Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women. Menopause 2009 2.07
16 Postmenopausal hormone therapy: does it cause incontinence? Obstet Gynecol 2005 1.94
17 Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol 2003 1.85
18 Less is more: how less health care can result in better health. Arch Intern Med 2010 1.77
19 Comparison of methods to measure low serum estradiol levels in postmenopausal women. J Clin Endocrinol Metab 2006 1.76
20 Predictors of heart failure among women with coronary disease. Circulation 2004 1.74
21 The WHI estrogen-alone trial--do things look any better? JAMA 2004 1.64
22 Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Am J Psychiatry 2005 1.62
23 Sex hormone levels and risk of breast cancer with estrogen plus progestin. J Natl Cancer Inst 2013 1.60
24 Evidence-based guidelines for cardiovascular disease prevention in women. J Am Coll Cardiol 2004 1.59
25 Menopausal symptoms in older women and the effects of treatment with hormone therapy. Obstet Gynecol 2002 1.57
26 Is diabetes mellitus a heart disease equivalent in women? Results from an international study of postmenopausal women in the Raloxifene Use for the Heart (RUTH) Trial. Circ Cardiovasc Qual Outcomes 2013 1.55
27 The "costs" of urinary incontinence for women. Obstet Gynecol 2006 1.52
28 Opioids for chronic pain. Arch Intern Med 2011 1.52
29 Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement. Arterioscler Thromb Vasc Biol 2004 1.49
30 Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease. Arterioscler Thromb Vasc Biol 2002 1.48
31 Why is a good clinical prediction rule so hard to find? Arch Intern Med 2011 1.38
32 Editor's Note--to make the case--evidence is required: comment on "Making the case for selective use of statins in the primary prevention setting". Arch Intern Med 2011 1.33
33 Effect of weight loss on urinary incontinence in overweight and obese women: results at 12 and 18 months. J Urol 2010 1.31
34 Persistent hot flushes in older postmenopausal women. Arch Intern Med 2008 1.28
35 Frequency and severity of hot flashes and sleep disturbance in postmenopausal women with hot flashes. Menopause 2009 1.23
36 Feasibility and acceptability of restorative yoga for treatment of hot flushes: a pilot trial. Maturitas 2006 1.22
37 Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women. Biol Psychiatry 2002 1.11
38 Association of total and central obesity with mortality in postmenopausal women with coronary heart disease. Am J Epidemiol 2003 1.10
39 Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life. Arch Neurol 2006 1.10
40 Commentary: Improving participant recruitment in clinical and translational research. Acad Med 2011 1.09
41 Dopamine receptor D4 (DRD4) gene in Han Chinese children with attention-deficit/hyperactivity disorder (ADHD): increased prevalence of the 2-repeat allele. Am J Med Genet B Neuropsychiatr Genet 2005 1.08
42 Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial. Obstet Gynecol 2004 1.06
43 The rise and fall of menopausal hormone therapy. Annu Rev Public Health 2005 1.04
44 A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer. Breast Cancer Res Treat 2010 1.03
45 Adaptive statistical iterative reconstruction reduces patient radiation dose in neuroradiology CT studies. Neuroradiology 2014 1.01
46 An intensive behavioral weight loss intervention and hot flushes in women. Arch Intern Med 2010 1.00
47 Restorative yoga in adults with metabolic syndrome: a randomized, controlled pilot trial. Metab Syndr Relat Disord 2008 1.00
48 Effect of raloxifene on stroke and venous thromboembolism according to subgroups in postmenopausal women at increased risk of coronary heart disease. Stroke 2008 0.97
49 Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial. Am J Cardiol 2002 0.96
50 Renal insufficiency as an independent predictor of mortality among women with heart failure. J Am Coll Cardiol 2004 0.94
51 Effects of raloxifene on fracture risk in postmenopausal women: the Raloxifene Use for the Heart Trial. J Bone Miner Res 2008 0.93
52 The effect of ultralow-dose transdermal estradiol on urinary incontinence in postmenopausal women. Obstet Gynecol 2005 0.91
53 Raloxifene and risk for stroke based on the framingham stroke risk score. Am J Med 2009 0.87
54 Clinical trials in stem cell transplantation: guidelines for scientific and ethical review. Clin Trials 2008 0.86
55 I Just Feel Terrible: Comment on "Why Physicians Work When Sick"I Just Feel Terrible. Arch Intern Med 2012 0.85
56 Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol. Obstet Gynecol 2005 0.84
57 Postmenopausal hormone therapy. BMJ 2007 0.83
58 Soy isoflavones for prevention of menopausal bone loss and vasomotor symptoms: comment on "Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms". Arch Intern Med 2011 0.82
59 Strengthening institutional review board review of highly innovative interventions in clinical trials. JAMA 2009 0.82
60 Hot flushes, bone mineral density, and fractures in older postmenopausal women. Obstet Gynecol 2007 0.81
61 Summary of the American Heart Association's evidence-based guidelines for cardiovascular disease prevention in women. Arterioscler Thromb Vasc Biol 2004 0.81
62 Alternatives to estrogen for treatment of hot flashes: are they effective and safe? JAMA 2006 0.81
63 The day-to-day impact of urogenital aging: perspectives from racially/ethnically diverse women. J Gen Intern Med 2009 0.81
64 Oophorectomy as a risk factor for coronary heart disease. Am J Obstet Gynecol 2008 0.80
65 Developing methods for less is more. JAMA Intern Med 2014 0.80
66 Miniature ambulatory skin conductance monitor and algorithm for investigating hot flash events. Physiol Meas 2014 0.79
67 Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol 2007 0.79
68 Evaluation of monoenergetic imaging to reduce metallic instrumentation artifacts in computed tomography of the cervical spine. J Neurosurg Spine 2015 0.79
69 Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years. Menopause 2006 0.78
70 Undertreatment improves, but overtreatment does not. JAMA Intern Med 2013 0.78
71 A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder. Am Heart J 2011 0.78
72 Raloxifene and colorectal cancer. J Womens Health (Larchmt) 2005 0.78
73 Placebo adherence and mortality in the Heart and Estrogen/Progestin Replacement Study. Am J Med 2012 0.77
74 The flip side of performance measures: limiting overtreatment. Arch Intern Med 2012 0.76
75 Device-guided slow-paced respiration for menopausal hot flushes: a randomized controlled trial. Obstet Gynecol 2015 0.76
76 Improving care at the end of life. Arch Intern Med 2011 0.75
77 Conservative use of prescription drugs: comment on "Communicating uncertainties about prescription drugs to the public". Arch Intern Med 2011 0.75
78 Evidence in clinical practice. Arch Intern Med 2012 0.75
79 Spinal augmentation for vertebral fracture. JAMA Intern Med 2013 0.75
80 Approaches to increase physical activity. JAMA Intern Med 2014 0.75
81 Helping women stop postmenopausal hormone therapy. Menopause 2006 0.75
82 Another reason to be cautious about imaging: comment on "association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism". Arch Intern Med 2012 0.75
83 Invited commentary--illuminating physicians' financial relationships with industry. Arch Intern Med 2011 0.75
84 Postmenopausal hormone treatment. JAMA 2009 0.75
85 Why physicians order tests. JAMA Intern Med 2013 0.75
86 Testing before seeing the patient. JAMA Intern Med 2015 0.75
87 How Much Vitamin D Is Enough? JAMA Intern Med 2015 0.75
88 Myocardial infarction during menses: lessons from trials and errors. Am J Med 2003 0.75
89 The "top 5" health care activities for which less is more: comment on "The 'top 5' lists in primary care". Arch Intern Med 2011 0.75
90 Electrocardiograms of menopausal women with coronary heart disease or at increased risk for its occurrence. Am J Cardiol 2010 0.75
91 On board with the Choosing Wisely campaign. JAMA Intern Med 2014 0.75
92 I just feel terrible. Arch Intern Med 2012 0.75
93 Reasons for overtreatment: comment on "Too little? Too much? Primary care physicians' views on US health care". Arch Intern Med 2011 0.75
94 Continuous transdermal nitroglycerin therapy for menopausal hot flashes: a single-arm, dose-escalation trial. Menopause 2016 0.75
95 A Simple Approach to Reducing Inappropriate Use of Central Venous Catheters. JAMA Intern Med 2015 0.75
96 A different perspective regarding prostate-specific antigen testing: in reply. Arch Intern Med 2012 0.75
97 Letters to the Editor. Menopause 2016 0.75
98 Improving quality of care at the end of life. Arch Intern Med 2012 0.75
99 Planning for closeout--from Day One. Contemp Clin Trials 2007 0.75
100 The effect of ultralow-dose transdermal estradiol on sexual function in postmenopausal women. Am J Obstet Gynecol 2008 0.75
101 Effect of hormone therapy on mortality rates among women with heart failure and coronary artery disease. Am J Cardiol 2005 0.75
102 Simplification of Insulin Regimens in Patients With Type 2 Diabetes. JAMA Intern Med 2016 0.75
103 Cardiac autonomic function and hot flashes among perimenopausal and postmenopausal women. Menopause 2017 0.75
104 Let's Get Another Tube-Just in Case. JAMA Intern Med 2016 0.75
105 Sleeping on the Street. JAMA Intern Med 2016 0.75
106 In Reply. Menopause 2017 0.75
107 Patient experience of overtreatment. Arch Intern Med 2011 0.75